News and Announcements
SUDA Annual Report to Shareholders 2016
- Published September 23, 2016 4:50PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
22nd September 2016, ASX Announcement
Letter From The Chairman
“Our global reputation in oro-mucosal drug delivery is growing as we continue to generate new discussion with potential partners as well as progressing existing discussions along the project cycle.”
Looking at the share price over the last 15 months suggests that the 2015-16 year was not a good year for SUDA, or for our shareholders. We continue to be very conscious of our shareholders’ expectations and anticipation of finalising licensing or sale agreements.
I would like to take this opportunity to provide further insight into our project developments, our achievements and our business development over the year.
To view the full announcement, please click on the button below.